Putnam Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,257
Closed -$621K 971
2019
Q3
$621K Sell
6,257
-236
-4% -$22.4K ﹤0.01% 791
2019
Q2
$600K Sell
6,493
-226,551
-97% -$21.5M ﹤0.01% 790
2019
Q1
$22M Sell
233,044
-292,168
-56% -$25.6M 0.05% 232
2018
Q4
$33.7M Buy
525,212
+363,323
+224% +$26.8M 0.09% 178
2018
Q3
$14.5M Sell
161,889
-331
-0.2% -$29.3K 0.03% 315
2018
Q2
$12.9M Sell
162,220
-227,554
-58% -$18.9M 0.03% 327
2018
Q1
$34.8M Buy
389,774
+33,339
+9% +$3.2M 0.08% 209
2017
Q4
$37.2M Sell
356,435
-1,842,779
-84% -$208M 0.08% 196
2017
Q3
$321M Sell
2,199,214
-83,354
-4% -$11.4M 0.74% 27
2017
Q2
$296M Sell
2,282,568
-847,353
-27% -$104M 0.69% 30
2017
Q1
$389M Sell
3,129,921
-330,598
-10% -$39.6M 0.91% 19
2016
Q4
$401M Sell
3,460,519
-49,585
-1% -$5.52M 0.97% 18
2016
Q3
$367M Sell
3,510,104
-382,689
-10% -$41.4M 0.88% 26
2016
Q2
$384M Buy
3,892,793
+16,830
+0.4% +$1.74M 0.94% 18
2016
Q1
$388M Buy
3,875,963
+285,116
+8% +$29.4M 0.92% 17
2015
Q4
$430M Buy
3,590,847
+174,232
+5% +$20.2M 0.97% 20
2015
Q3
$370M Sell
3,416,615
-576,051
-14% -$71.5M 0.83% 22
2015
Q2
$462M Buy
3,992,666
+404,950
+11% +$46.3M 0.93% 17
2015
Q1
$414M Buy
3,587,716
+184,404
+5% +$22M 0.82% 20
2014
Q4
$381M Buy
3,403,312
+31,757
+0.9% +$3.35M 0.78% 21
2014
Q3
$320M Sell
3,371,555
-350,122
-9% -$31.6M 0.68% 28
2014
Q2
$320M Buy
3,721,677
+120,503
+3% +$9.16M 0.69% 25
2014
Q1
$251M Sell
3,601,174
-109,362
-3% -$8.66M 0.57% 41
2013
Q4
$313M Sell
3,710,536
-157,524
-4% -$12.5M 0.75% 21
2013
Q3
$298M Buy
3,868,060
+321,648
+9% +$22.5M 0.8% 19
2013
Q2
$207M Buy
+3,546,412
New +$213M 0.6% 35

Other funds holding CELG

Putnam Investments's CELG Position: Q4 2019 in Review

Putnam Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,257 shares — an estimated $621K sold.

Putnam Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $462M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Putnam Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Putnam Investments sold 6,257 Celgene Corp shares in Q4 2019, an estimated $621K.
  • Putnam Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Putnam Investments's Celgene Corp position peaked at $462M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Putnam Investments's 13F filing for Q4 2019, filed 14 Feb 2020.